Business & Tech, Featured Raising Taxes or Cutting Spending: House Budget Committee Argues Over Debt Crisis Fix WASHINGTON –– Republicans and Democrats clashed on May 7 at a House Budget Committee hearing over how to address the nation’s mounting federal debt—whether to raise revenue through tax increases or cut spending on federal ... CONTINUE READING Business & Tech, Featured DMV residents share thoughts on the economy 100 Days into Trump's administration By Huiyan Li, Athan Yanos WASHINGTON–Following the 100th day of Donald Trump’s second term as president, polls showed that Americans were increasingly worried about their economic future. On Day 101, two Medill reporters set out across neighborhoods ... CONTINUE READING Business & Tech Tariffs and economic uncertainty take center stage at Small Business Expo WASHINGTON - Christina Callahan served sparkling Portuguese rose wine imported by the small District of Columbia business, The Wine Concierge, where she is chief sommelier. However, she suggested that for small businesses that rely on imports ... CONTINUE READING Business & Tech, Featured Advocates, professors, and diplomats tried to save Sub-Saharan Africa's special trade relationship with the U.S WASHINGTON –– Facing expiration of a law that provided beneficial markets for 2,000 products from African partners for 25 years, advocates, professors, diplomats and members of the US government strategize on ways to preserve economic ... CONTINUE READING

 

Farmers need AI, could miss out

Farmers need AI, could miss out

As artificial intelligence spreads into agriculture, senators stressed that all farms need broadband access in order to take advantage of all the ways AI can boost production.

Did the Great Resignation really happen? Most workers are staying put.

The so-called Great Resignation — the historic jump in the number of Americans quitting jobs — may not be so great after all. The average length of time an American worker stays at a job, it turns out, is the same compared to pre-pandemic times, according to a new government survey.

New FDA program could boost drug development for rare diseases

A proposed FDA pilot, the Rare Disease Endpoint Advancement program, aims to bolster clinical trials for rare diseases by increasing collaboration between industry and the FDA to determine meaningful endpoints for rare diseases in clinical trials.

Stay Connected

Medill Today | Thursday, May 29, 2025

 

 

 

Medill on Vimeo

Check out hundreds of video stories from our reporters.

Medill on Twitter

Stay current with our news updates by the minute.

Medill on Tumblr

Get a solid stream of news from our reporters.

Medill on Snapchat

MedillontheHill

preload imagepreload image